NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

He discussed that there have been numerous advancements in the field over the years. For example, look at UCLA where they discuss functional mapping and awake surgery. Not only are we seeing more complete resections, but also resections of boarderline areas that previously would not have been touched out of concern for damage.

His conclusion was that what is important is that the center have advanced technology and the doctor be expert at using it. Not that any one technology was the key.

Sounds like a rationalisation (read excuse) for not having 5-ALA available.

Though for me, 5-ALA remains a leading contender for the cause of the partial hold.
(Regulator discovers fluoresced tumor tissue has been used in production of L. And then asks the question; 'how do you know that use of fluoresced tissue doesn't alter safety / efficacy?' and then proceeds to require a lengthy equivalency test before further use of fluoresced tissue is allowed....)